High Intensity Focused Ultrasound Therapy Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.To Evaluate the Efficacy of Toripalimab Combined With Chemotherapy After HIFU Induction in the Treatment of Early Triple-negative Breast Cancer
Conditions: Breast Cancer; TNBC - Triple-Negative Breast Cancer Interventions: Drug: Toripalimab; Drug: Epirubicin; Procedure: High Intensity Focused Ultrasoun; Drug: Cyclophosphamide; Drug: Carboplatin; Drug: Nab-paclitaxel Sponsor: The First Affiliated Hospital with Nanjing Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2022 Category: Research Source Type: clinical trials
